Abstract Library

#742 Evaluation of Relevant Factors of Prognosis Among a Large German Multi-Centric Cohort–Results from the German NET Registry

Introduction: Neuroendocrine neoplasms (NEN) are a rare tumor entity with varying biological behavior.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Maasberg S

Authors: Maasberg S, Begum N, Auernhammer C, Ezziddin S, Pöppel T,

Keywords: outcome, prognostic factors,

#610 Effectiveness of PRRT for NETs in Germany: An Analysis of 450 Patients

Introduction: Peptide receptor radionuclide therapy targets somatostatin receptors expressed on well-differentiated neuroendocrine neoplasms. Retrospective monocentric studies indicate that peptide receptor radionuclide therapy is an effective treatment for patients with neuroendocrine neoplasms.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Hörsch D

Authors: Hörsch D, Ezziddin S, Haug A, Gratz K, Dunkelmann S,

Keywords: PRRT,

#450 Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors in Germany: First Results of a Multiinstitutional Cancer Registry

Introduction: Peptide receptor radionuclide therapy is an effective treatment option for patients with well-differentiated somatostatin receptor expressing neuroendocrine tumors. However, published data results mainly from retrospective monocentric studies.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Hörsch D, Ezziddin S, Haug A, Gratz K, Dunkelmann S,

Keywords: PRRT, Yttrium, Lutetium, SMS Receptor,